Aktis Oncology is a Biotech company based in Boston, MA. It has raised $175M in total funding. Latest round: Series B.
Aktis Oncology funding overview
Aktis Oncology is a Biotech company based in Boston, MA. Aktis Oncology has raised $175M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B. Investors on record include RA Capital Management, RTW Investments, Janus Henderson Investors. 3 distinct backers are named across the disclosed rounds.
Aktis Oncology at a glance
Total raised
$175M
Latest round
Series B
Industry
Biotech
Headquarters
Boston, MA
Notable investors
RA Capital Management, RTW Investments, Janus Henderson Investors
Frequently asked about Aktis Oncology funding
How much has Aktis Oncology raised?
Aktis Oncology has raised $175M in total disclosed funding across the rounds on record.
Who has invested in Aktis Oncology?
RA Capital Management, RTW Investments, Janus Henderson Investors are named among the investors backing Aktis Oncology.
What was the latest Aktis Oncology funding round?
The most recent disclosed round is a Series B.
Where is Aktis Oncology based?
Aktis Oncology is based in Boston, MA.
What sector does Aktis Oncology operate in?
Aktis Oncology is tracked under Biotech from Boston, MA, with $175M in disclosed funding.
We update the Aktis Oncology record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Boston and their backers are listed below.
